期刊文献+

左旋卡尼汀对老年腹部术后心力衰竭患者的疗效分析 被引量:2

Clinical effect of L-carnitine on postoperative congestive heart failure of elderly patients following abdominal operation
下载PDF
导出
摘要 目的观察左旋卡尼汀治疗老年腹部术后心力衰竭患者的临床疗效。方法选择腹部手术后并发心力衰竭老年患者57例,随机分为2组,对照组25例予洋地黄、利尿剂、血管扩张剂、血管紧张素转换酶抑制剂等常规药物治疗,卡尼汀组32例,在常规治疗的基础上加用国产左旋卡尼汀5.0g治疗15d。结果两组治疗后临床症状和射血分数(EF)较治疗前均有改善,但卡尼汀组心功能改善的临床显效率(44%)和总有效率(94%)均较对照组(36%和80%)显著提高(分别为P<0.05和P<0.01),治疗后卡尼汀组EF(0.52±0.03)与对照组(0.50±0.04)和治疗前(0.48±0.05)相比,差别均有显著性意义(均P<0.01),且无药物不良反应。结论左旋卡尼汀辅助治疗老年腹部术后心力衰竭患者有较好疗效。 AIM To evaluate the clinical effect of L-carnitine (L-CN) on postoperative congestive heart failure of elderly patients who had undergone abdominal operation. METHODS Fifty-seven elderly patients with postoperative congestive heart failure following abdominal operation were randomly divided into control group receiving conventional treatment (digitalis, diuretics, vasodilator, ACEI) and L-CN group (conventional treatment combined with L-CN). The treatment course was 15 days. RESULTS There was some difference in heart function changes in two groups before and after treatment. But the effective rate in improving heart function was 94% in L- CN group and 80% in control group (P 〈0.01 ). Significant difference in left ventricular ejecting fraction was found between the two groups after treatment (P 〈 0.05). No adverse effects of the drug were observed. CONCLUSION L-CN combined with conventional treatment effectively improves the heart function when used to treat the postoperative congestive heart failure of elderly patients who have undergone abdominal operation.
出处 《心脏杂志》 CAS 2007年第3期326-328,共3页 Chinese Heart Journal
关键词 心力衰竭 充血性 左旋卡尼汀 心功能 heart failure , congestive L-carnitine heart function
  • 相关文献

参考文献8

二级参考文献19

  • 1陈妙茹 邓斌.左旋肉毒碱治疗冠心病心绞痛疗效观察.实用医学杂志,2000,16(2):183-185.
  • 2Bremer J. Carnitine metabolism and function [J]. Physiol Res, 1983,63:1420-1428.
  • 3Regitz V, Shug AL, Fleck E. Defective myocardial metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary hypertensive and valvular heart disease[J]. Am J Cardiol,1990,65: 755-803.
  • 4Yusuf S, Sleight P, Pogue J, et al. Effects of angiotensin-converting enzyme, ramipil, on cardiovascular events in high 0risk patients. The Heart Outcomes Prevention Evaluation Study Investigators[J]. N Engl J Med, 2000,342(3):145-153.
  • 5Pott B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J]. N Engl J Med, 1999,341;709-717.
  • 6Anand I , Chandranshekhan Y , De Giuli F , et al. Acute and chronic effects of propionyl-carnitine on the hemodynamics, exercise capacity , and hormones in patients with congestive heart failure[J]. Cardiovasc Drugs Ther, 1988,12:291-308.
  • 7殷仁富 陈金明.心脏能量学[M].上海:第二军医大学出版社,2002.6.
  • 8Calvani M, Reda E, Arrigoni-Martelli E. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions [ J ]. Basic Res Cardiol, 2000, 95 ( 2 ) :75 - 83.
  • 9Neumar RW, Lathers CM, Turner N, et al. Myocardial high energy phosphate metabolism during ventricular fibrillation with total circulatory arrest [J]. Resuscitation, 1990, 19(3) :199 -226.
  • 10Hwang YC, Bakr S, Rarnasarny R, et al. Relative importance of enhanced glucose uptake versus attenuation of long-chain acyl carnitines in protecting isehemic myocardium [ J ]. Coron Artery Dis, 2002, 13(6) :313 -318.

共引文献28

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部